Aegerion Pharmaceuticals Revenue Quarterly:1.231M for March 31, 2013
Aegerion Pharmaceuticals Revenue Quarterly Chart
Aegerion Pharmaceuticals Historical Revenue Quarterly DataPro Data Export
There is no data for the selected date range.
|Data for this Date Range|
|March 31, 2013||1.231M|
|Dec. 31, 2012||0.00|
|Sept. 30, 2012||0.00|
|June 30, 2012||0.00|
|March 31, 2012||0.00|
|Dec. 31, 2011||0.00|
|Sept. 30, 2011||0.00|
|June 30, 2011||0.00|
|March 31, 2011||0.00|
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.
While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
AEGR Revenue Quarterly Benchmarks
AEGR Revenue Quarterly Rankings
4660 of 7600
434 of 653 in Healthcare
40 of 66 in Drug Manufacturers - Specialty & Generic
AEGR Revenue Quarterly Range, Past 5 Years
Fool May 18